Interleukin-12 is produced by antigen-presenting cells and regulates t
he balance between TH1/TH2, lymphocyte subsets, promoting cell-mediate
d immune reactions. Amongst patients with chronic hepatitis B undergoi
ng interferon-alpha treatment, only those who clear hepatitis B virus
show a substantial increase in the production of biologically active I
L-12 and an inverse ratio between serum levels of IL-12p40 subunit and
IL-12, The peak of serum IL-12, occurs after the hepatitis flare and
precedes or coincides with the time of HBe seroconversion, These data
indicate that IL-12 is an important element for establishing the host
immune control on hepatitis B virus replication in patients with chron
ic hepatitis B virus infection.